Search - tctmd.com

Displaying 81 - 100 of 1423

Sort: Relevancy | Date

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

April 03, 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

News Conference News ACC 2025

PCI Rebounds at 5 Years to Mostly Match CABG: Final FAME 3 Data

March 31, 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

News Conference News ACC 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

March 31, 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

News Conference News EHRA 2025

Chronic HF Patients Needing CRT Fare Better With LBB Pacing: HeartSync-LBBP

March 31, 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

March 30, 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

March 30, 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

Yael L. Maxwell

March 29, 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

March 29, 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

March 10, 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

February 21, 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

February 19, 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

February 18, 2025

Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

News Conference News

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

Yael L. Maxwell

February 18, 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

February 14, 2025

Electrical Brain Stimulation Fails to Improve Poststroke Recovery

News Conference News ISC 2025

Electrical Brain Stimulation Fails to Improve Poststroke Recovery

February 10, 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

News Conference News STS 2025

Surgery Outdoes Percutaneous Treatment for Patients With CAD, Aortic Stenosis

Yael L. Maxwell

February 05, 2025

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

News Conference News STS 2025

With Limited RCTs of Arterial Grafting, Researchers Take a Different Tack

Yael L. Maxwell

January 31, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.